Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001390064 | SCV001591658 | pathogenic | Cerebral cavernous malformation 2 | 2020-10-27 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2-10 of the CCM2 gene, which encodes ~98% of the total protein. The boundaries of this event are unknown, as the deletion extends beyond the assayed region for this gene and therefore may include exon 1 of the CCM2 gene (resulting in complete gene deletion) and/or encompass additional genes. Loss-of-function variants in CCM2 are known to be pathogenic. A deletion of exons 2-10 that is mediated by Alu repeat sequences in intron 1 and the intragenic region downstream of exon 10 has been reported in several individuals with cerebral cavernous malformations (PMID: 17160895). For these reasons, this variant has been classified as Pathogenic. |